PTPRC and neoplasm: Immunostaining showed that the tumor was strongly positive for Vimentin, Desmin and MyoD1, and was negative for CK, P63, NSE, CD45, CD30, S-100, CD99, Myoglobin, CD68, CD34, CD31, α–SMA.